J&J Snack Foods (JJSF) doesnt possess the right combination of the two key ingredients for a likely earnings beat in…
Drugs giant Johnson & Johnson will report fourth-quarter and full-year earnings early Tuesday. Earlier this month, it had warned the…
NEW YORK and JERUSALEM, Jan. 23, 2023 /PRNewswire/ -- Immunyx Pharma, a developer of immune modulating therapies for neutrophil based…
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Earnings will be the focus on Monday and the coming days this week. General Electric, Johnson &…
Earnings will be the focus on Monday and the coming days this week. General Electric, Johnson & Johnson, Verizon, Microsoft,…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
In Rekordzeit wurden Impfstoffe gegen Corona entwickelt. Doch noch immer gibt es keinen Impfstoff gegen HIV. Erst in der vergangenen…
Elon Musk Reveals "Major Side Effects" After 2nd COVID Booster
…
Federal prosecutors say a subsidiary of health care company Johnson & Johnson has agreed to pay nearly $10 million to…
Johnson & Johnson stock underperforms Friday when compared to competitors...…
...By Jonathan Stempel
(Reuters) - Johnson & Johnson and its DePuy......…
...By Jonathan Stempel
Jan 20 (Reuters) - Johnson & Johnson and its......…
DUBLIN, Jan. 20, 2023 /PRNewswire/ -- The "Electrosurgical Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key…
Latest Ratings for JNJ
DateFirmActionFromTo Jan 2022Raymond JamesMaintainsOutperform Jan 2022Morgan StanleyMaintainsEqual-Weight Dec 2021Goldman SachsInitiates Coverage OnNeutral
…
Growth in J&Js (JNJ) Pharma unit is expected to have been driven by drugs like Darzalex and Stelara. In the…
Johnson & Johnson stock falls Thursday, still outperforms market...…
BERLIN (dpa-AFX) - Ein besonders aussichtsreicher Impfstoffkandidat gegen die Immunschwächekrankheit Aids schützt nicht ausreichend vor einer HIV-Infektion. Das gab der…
BERLIN (dpa-AFX) - Ein besonders aussichtsreicher Impfstoffkandidat gegen die Immunschwächekrankheit Aids schützt nicht ausreichend vor einer…
Wien (www.aktiencheck.de) - Nachdem im Technologiesektor schon einige Unternehmen Personalkürzungen angekündigt hatten, gab gestern auch Microsoft (ISIN: US5949181045, WKN: 870747,…
In the latest trading session, Johnson & Johnson (JNJ) closed at $169.76, marking a -1.51% move from the previous day....…
Johnson & Johnson stock outperforms competitors despite losses on the day...…
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson’s JNJ experimental HIV vaccine is safe but not effective, and the late-stage study will be discontinued as…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
...
trials)
Jan 18 (Reuters) - Johnson & Johnson said on
Wednesday......…
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
...(Reuters) - Johnson & Johnson said on Wednesday the company......…
STOCKHOLM January 18, 2023
Annexin Pharmaceuticals AB (publ) announces that Dr. Thibault, a medical oncologist with extensive global experience leading…
Johnson & Johnson stock falls Tuesday, underperforms market...…
We believe that pharmaceutical giants Johnson & Johnson stock (NYSE: JNJ) and Merck stock (NYSE: MRK) will likely offer similar…
Johnson & Johnson stock falls Friday, underperforms market...…
Johnson & Johnson (NYSE: JNJ) has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in…
After mobilizing to quickly develop and manufacture a Covid-19 vaccine, Johnson & Johnson has vastly scaled back its efforts in…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson stock falls Thursday, underperforms market...…
Johnson & Johnson stock falls Wednesday, underperforms market...…
In the latest trading session, Johnson & Johnson (JNJ) closed at $175.16, marking a -0.24% move from the previous day....…
Johnson & Johnson stock underperforms Tuesday when compared to competitors...…
NEW YORK, Jan. 9, 2023 /PRNewswire/ -- Premium cosmetics market insights - Vendors: 15+, including Amway Corp., Avon Products, Beiersdorf…
Johnson & Johnson stock underperforms Monday when compared to competitors...…
Merck, Johnson & Johnson share losses lead Dow's 36-point fall...…
...By Leroy Leo and Aditya Samal
(Reuters) - Johnson & Johnson......…
Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson (NYSE:JNJ).
And retail traders…
Americans love their snack foods -- and the sales numbers show it....…
Johnson & Johnsons upcoming spinoff could lead to better returns, and itll happen before 2024....…
Johnson & Johnson stock rises Friday, still underperforms market...…
A filing by a J&J unit for a corporate carve-out highlights what some see as a corporate opportunity during soft…
Johnson & Johnson stock outperforms competitors despite losses on the day...…
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts…
Kenvue Inc. KVUE , the consumer products unit of Johnson & Johnson JNJ, late Wednesday filed its initial public offering…